indazoles has been researched along with gsk 2126458 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maslen, SL; Masson, GR; Williams, RL | 1 |
1 other study(ies) available for indazoles and gsk 2126458
| Article | Year |
|---|---|
Analysis of phosphoinositide 3-kinase inhibitors by bottom-up electron-transfer dissociation hydrogen/deuterium exchange mass spectrometry.
Topics: Antineoplastic Agents; Binding Sites; Class I Phosphatidylinositol 3-Kinases; Class Ia Phosphatidylinositol 3-Kinase; Deuterium Exchange Measurement; Drug Evaluation, Preclinical; Electron Transport; Enzyme Inhibitors; Humans; Indazoles; Models, Molecular; Molecular Weight; Oligonucleotides; Peptide Fragments; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Conformation; Purines; Pyridazines; Quinazolinones; Quinolines; Recombinant Fusion Proteins; Reproducibility of Results; Signal Processing, Computer-Assisted; Sulfonamides; Tandem Mass Spectrometry; Triazines | 2017 |